Israel to Expand Trade Eastward as It Looks Beyond War Economy
Israel is turning to markets in the Arabian Peninsula and India to boost trade as the government seeks to increase exports from $150 billion to almost $1 trillion over the next 15 years, according to Economy and Industry Minister Nir Barkat.
The government has identified Dubai, the Middle East's center for trade, finance and tourism, as a hub for the expansion, Barkat said in an interview in the city last week. About 600 Israeli companies have started working in the United Arab Emirates since the two countries established diplomatic relations as part of the US-brokered Abraham Accords in 2020, he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
SINOVAC Board of Directors Prevails Against Advantech/Prime's New York Lawsuit
BEIJING--(BUSINESS WIRE)--SINOVAC Biotech Ltd. (NASDAQ: SVA) (' SINOVAC ' or the ' Company '), a leading provider of biopharmaceutical products in China, today announced it has prevailed against Advantech/Prime Success' ('Advantech/Prime') Petition for Emergency Injunctive Relief in the U.S. District Court for the Southern District of New York. The result in the New York court represents another failure in the campaign by Advantech/Prime in coordination with Vivo Capital (together known as the 'Dissenting Investor Group') to wrest control of SINOVAC from its recently installed, lawfully-elected Board of Directors (the 'current SINOVAC Board') in accordance with the Privy Council order and Antiguan Law, and to interfere with the payment of the US$55.00 per common share special cash dividend declared by the current SINOVAC Board. Following the New York court's ruling, the current SINOVAC Board is free to pursue its legal action in Antigua seeking to cancel the PIPE shares invalidly issued to the Dissenting Investor Group by the former illegitimate board (the 'Imposter Former Board'). If the current SINOVAC Board succeeds in legal proceedings on the PIPE shares, it has announced its intention to redistribute an additional US$11.00 per common share to SINOVAC's valid shareholders. Dr. Chiang Li, Chairman of the SINOVAC Board, commented, 'We will continue our mission to restore fairness and deliver value to all valid SINOVAC shareholders, starting with paying the $55.00 per share special cash dividend as soon as July 7, 2025.' The Dissenting Investor Group's self-serving, multi-pronged lawfare strategy against SINOVAC has one goal: to prevent all valid SINOVAC common shareholders from receiving any dividend payments unless the Dissenting Investor Group receives an allocation for their invalid PIPE shares, despite the fact that they have already received over US$1 billion in dividends from a SINOVAC operating subsidiary. The current SINOVAC Board has set aside in escrow the pro rata portion of dividends for the PIPE shares — funds the Dissenting Investor Group could receive if the legal proceedings they initiated rule in their favor. The current SINOVAC Board is fighting back – and winning. We feel certain that we will prevail against any further legal action by the Dissenting Investor Group and look forward to ensuring all valid shareholders receive their fair share. Your Vote is Important Your vote on or before July 8 will be about the future of SINOVAC, your receipt of your make-whole dividend payments in the near-term, and the long-term value of your investment. We urge you to keep SINOVAC's Board in place and vote on the WHITE proxy card ' AGAINST ' Proposal 1 to remove the current Board and ' AGAINST ' Proposal 2 to appoint the Reconstituted Imposter Board Slate. Your vote is critical to ensuring that SINOVAC remains on the path to stability, growth, and value creation for all shareholders. DISCARD any items you received asking you to vote for the Reconstituted Imposter Former Board Slate. If you have already voted for the Reconstituted Imposter Former Board Slate, you can subsequently revoke it by using the WHITE proxy card or WHITE voting instruction form to vote. Only your latest-dated vote will count! If you have questions about how your vote can be counted, please contact our proxy solicitor, Georgeson LLC, toll free at (844) 568-1506 in the U.S. and (646) 543-1968 outside the U.S. or via email at SinovacSpecialMeeting@ About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected Hand-Foot-Mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalification requirements in 2017. The EV71 vaccine, Inlive®, is an innovative vaccine under "Category 1 Preventative Biological Products" and commercialized in China in 2016. In 2022, SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO. SINOVAC was the first company to be granted approval for its H1N1 influenza vaccine Panflu.1®, which has supplied the Chinese government's vaccination campaign and stockpiling program. The Company is also the only supplier of the H5N1 pandemic influenza vaccine, Panflu®, to the Chinese government stockpiling program. SINOVAC continually dedicates itself to new vaccine R&D, with more combination vaccine products in its pipeline, and constantly explores global market opportunities. SINOVAC plans to conduct more extensive and in-depth trade and cooperation with additional countries, and business and industry organizations. Important Additional Information and Where to Find It In connection with SINOVAC's Special Meeting, SINOVAC has filed with the U.S. Securities and Exchange Commission ('SEC') and mailed to shareholders of record entitled to vote at the Special Meeting a definitive proxy statement and other documents, including a WHITE proxy card. SHAREHOLDERS ARE ENCOURAGED TO READ THE PROXY STATEMENT AND ALL OTHER RELEVANT DOCUMENTS WHEN FILED WITH THE SEC AND WHEN THEY BECOME AVAILABLE BECAUSE THOSE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION. Investors and other interested parties will be able to obtain the documents free of charge at the SEC's website, or from SINOVAC at its website: You may also obtain copies of SINOVAC's definitive proxy statement and other documents, free of charge, by contacting SINOVAC's Investor Relations Department at ir@ Safe Harbor Statement This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as 'may,' 'will,' 'expect,' 'anticipate,' 'aim,' 'estimate,' 'intend,' 'plan,' 'believe,' 'potential,' 'continue,' 'is/are likely to' or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company's or Board's control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
Yahoo
3 hours ago
- Yahoo
Building a $28,000 TFSA Portfolio One Contribution at a Time
Written by Adam Othman at The Motley Fool Canada Ever since central banks in the US and Canada started cutting key interest rates, economic activity has picked up pace in both countries. While the rate cuts are currently paused amid trade and geopolitical tensions, analysts predict two more rate cuts of 25 basis points as inflation and tariff-related headwinds ease. Lower interest rates also mean you cannot generate too much interest income from cash held in high-interest savings accounts. If you have $28,000 of contribution room available in a Tax-Free Savings Account (TFSA), I can tell you a much better way of generating good monthly returns. The TSX has no shortage of monthly dividend-paying stocks. Building a portfolio of high-quality TSX stocks paying monthly distributions to shareholders can be a great way to generate extra monthly income. Here's a table giving you a quick look at how a hypothetical amount of around $28,000 across three such TSX stocks can deliver $144 in monthly dividends in a TFSA without incurring taxes. After that, you can read a bit about each. Ticker Recent Price Number of Shares Amount Invested Monthly Dividends Per Share Total Monthly Payout Per Stock PZA $14.91 625 $9,318.75 $0.0775 $48.44 SIA $18.52 503 $9,315.56 $0.078 $39.23 $25.37 368 $9,336.16 $0.1542 $56.75 Total Monthly Payout $144.42 Pizza Pizza Royalty Corp. (TSX:PZA) is a $497.3 million market-cap company that owns and franchises quick-service restaurants under several brands, boasting almost 800 restaurants from one coast to the other. The monthly dividend-paying stock generates revenue by collecting royalties from its franchisees based on how much they sell, making its cash flows less vulnerable to wage increases or commodity price fluctuations, which weigh on many businesses in the industry. The brands under the company's banner consistently keep adding value to end consumers by updating menus and using creative brand messaging. The company is also planning to continue to increase its locations. I believe this stock can be a good investment for earning relatively safe monthly dividends. Sienna Senior Living Inc. (TSX:SIA) is a $1.7 billion market-cap giant in the senior living space. It is among the largest owners of senior housing facilities in Ontario, servicing the aging population. Occupancy rates are getting higher and higher, and it generates revenue from several business segments catering to different markets within Canada. As long as the growth in the senior population continues, so will the demand for the services that SIA stock offers. The company ended the first quarter of fiscal 2025 with $445 million in liquidity, indicating that it has more than enough capital to fund monthly dividends and acquire more facilities under its banner. It can be another solid investment to consider for monthly dividends. SmartCentres REIT (TSX: is a Real Estate Investment Trust (REIT) that can help you earn monthly income like a lazy landlord. If you have the cash outlay for stock market investing, you have the ability to invest in the real estate sector, all without the hassle of being an actual landlord. has a portfolio of almost 200 properties in key locations across the country, with over 95% of its tenants having a regional or national presence. Most of its revenue comes from commercial tenants offering essential services, giving it solid cash-generating opportunities. Boasting an impressive 98.4% occupancy rate, it can be a solid investment. I feel that you should take any opportunity you can to make more money, and the TFSA gives you the perfect chance to do that. The tax-sheltered nature of the account means you can enjoy the returns from your investments in the account without incurring taxes. The table at the start paints a picture of what the monthly income might look like with a hypothetical $28,000 across three monthly dividend stocks. Add capital gains in the long term into the mix and your total returns over a few years can be much higher. The post Building a $28,000 TFSA Portfolio One Contribution at a Time appeared first on The Motley Fool Canada. More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool recommends SmartCentres Real Estate Investment Trust. The Motley Fool has a disclosure policy. 2025
USA Today
9 hours ago
- USA Today
Israel may run low on missile interceptors, putting US in a 'bind'
If the U.S. chooses to replenish Israel's missile interceptors, it may have to draw them from other stockpiles. As Israel downs incoming volleys of Iranian missiles, a shortage of its missile interceptors could put both the United States and Israel in a bind. After a week of its aerial war with Iran, Israel's long-range Arrow interceptors are running low, the Wall Street Journal reported on June 18. In addition to Arrow interceptors, which are Israeli-made, Israel also has U.S.-made THAAD systems, which intercept medium-range ballistic missiles. If the United States chooses to replenish Israel's missile interceptors, it would mean drawing from other stockpiles, since Congress wouldn't have time to surge U.S. defense production of more, according to Brandan Buck, a research fellow at the Cato Institute. That could include siphoning off interceptors marked off for delivery to Ukraine, to Taiwan in a possible future conflict, or from the U.S.'s own national stock, Buck said. "If they truly do run out... that's going to put us in a position in which we have to make some serious decisions," Buck said. "It's going to put the U.S. and Israel in a bit of a bind," he added. The U.S. could also position some naval ships off the coast to "augment some of their capacity," according to Buck. The USS Nimitz, a massive aircraft carrier, is en route to the region and will arrive in less than a week, USA TODAY previously reported. It will join the USS Carl Vinson, which moved to the Middle East in April. When Iran launched a volley of ballistic missiles at Israel in October, the U.S. helped to intercept its attacks using interceptors fired from two other U.S. warships. The U.S. spends $3.4 billion to bolster Israel's missile defense every year, including $1.3 billion for its Iron Dome, according to the State Department. Iran could still have thousands of missiles in its arsenal Israel keeps information about its missile interceptor stockpiles tightly under wraps. Its military said on June 16 that it had taken out a third of Iran's missile launchers. Israel says its missile defense success rate stands at greater than 90% against Iran's attacks in the ongoing aerial war. Still, some have evaded Israel's defenses, including the missile that struck a hospital in southern Israel on Thursday. It's also unclear exactly how many missiles Iran has left. The Pentagon estimated in 2021 that Iran just under 3,000 missiles of different ranges. Since Israel attacked Iran on June 12 through June 16, Iran had fired around 370 missiles, meaning thousands could remain. Israel's multilayered air defense system is designed to take down incoming missives from a variety of ranges. The Iron Dome intercepts missiles and rockets fired from a short range of up to around 45 miles, and David's Sling intercepts cruise missiles and rockets at a range of up to about 125 miles. The longer-range missiles fired by Iran are picked up by the Israeli-made Arrow 2 and Arrow 3 systems, which intercept ballistic missiles at a range of up to around 60 miles and 1,500 miles, respectively. In October, the United States sent Israel a THAAD system – capable of intercepting missiles inside and outside of the atmosphere – including American personnel to operate it. According to news reports, the United States sent a second THAAD to Israel in April, although the Pentagon has not publicly confirmed the transfer. The U.S. Army has just seven THAAD batteries in total – it will get an eighth later this summer.
